Nancy François

474 total citations
23 papers, 393 citations indexed

About

Nancy François is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Nancy François has authored 23 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 21 papers in Microbiology and 1 paper in Infectious Diseases. Recurrent topics in Nancy François's work include Pneumonia and Respiratory Infections (23 papers), Bacterial Infections and Vaccines (21 papers) and Influenza Virus Research Studies (12 papers). Nancy François is often cited by papers focused on Pneumonia and Respiratory Infections (23 papers), Bacterial Infections and Vaccines (21 papers) and Influenza Virus Research Studies (12 papers). Nancy François collaborates with scholars based in Belgium, India and United Kingdom. Nancy François's co-authors include Dorota Borys, Lode Schuerman, Kristien Swinnen, Menno R. van den Bergh, Reinier H. Veenhoven, Judith Spijkerman, Elisabeth A. M. Sanders, Thierry Pascal, E. P. F. IJzerman and Jacob P. Bruin and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and BMC Public Health.

In The Last Decade

Nancy François

23 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy François Belgium	10	355	222	47	33	25	23	393
Judith Spijkerman Netherlands	9	487 1.4×	257 1.2×	52 1.1×	20 0.6×	33 1.3×	10	522
Francesco Nieddu Italy	12	306 0.9×	205 0.9×	52 1.1×	28 0.8×	47 1.9×	35	367
Angelique G.S.C. Jansen Netherlands	6	289 0.8×	89 0.4×	42 0.9×	15 0.5×	17 0.7×	7	310
Kinga Meszaros Belgium	10	228 0.6×	234 1.1×	25 0.5×	65 2.0×	24 1.0×	16	305
Rodrigo Vergara Chile	7	256 0.7×	270 1.2×	17 0.4×	20 0.6×	69 2.8×	8	346
E. C. Anderson United Kingdom	8	278 0.8×	292 1.3×	36 0.8×	14 0.4×	32 1.3×	8	360
J. F. Noyes United States	3	473 1.3×	228 1.0×	28 0.6×	25 0.8×	17 0.7×	4	507
Jane Nelson Australia	8	187 0.5×	80 0.4×	14 0.3×	20 0.6×	66 2.6×	13	281
María Florencia Lución Argentina	9	179 0.5×	77 0.3×	43 0.9×	47 1.4×	53 2.1×	32	220
María Del Valle Juárez Argentina	10	181 0.5×	100 0.5×	39 0.8×	54 1.6×	65 2.6×	32	233

Countries citing papers authored by Nancy François

Since Specialization

Citations

This map shows the geographic impact of Nancy François's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy François with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy François more than expected).

Fields of papers citing papers by Nancy François

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy François. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy François. The network helps show where Nancy François may publish in the future.

Co-authorship network of co-authors of Nancy François

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy François. A scholar is included among the top collaborators of Nancy François based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy François. Nancy François is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nunes, Marta C., Marta Moreira, Anthonet Koen, et al.. (2020). Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Review of Vaccines. 19(12). 1177–1189. 3 indexed citations

Madhi, Shabir A., Marta Moreira, Anthonet Koen, et al.. (2020). Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 38(10). 2350–2360. 4 indexed citations

Szenborn, Leszek, Hanna Czajka, С. М. Харит, et al.. (2017). Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2–17-year-old children with asplenia or splenic dysfunction: A phase 3 study. Vaccine. 35(40). 5331–5338. 5 indexed citations

Madhi, Shabir A., Anthonet Koen, Lisa Jose, et al.. (2017). Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine. 96(2). e5881–e5881. 14 indexed citations

Silfverdal, Sven‐Arne, et al.. (2016). Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Expert Review of Vaccines. 16(2). 109–121. 7 indexed citations

Sirima, Sodiomon B., Alfred B. Tiono, Mohamadou Siribié, et al.. (2016). Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age. The Pediatric Infectious Disease Journal. 36(5). e136–e150. 7 indexed citations

Wysocki, Jacek, Jerzy Brzostek, Ryszard Konior, et al.. (2016). Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies. Human Vaccines & Immunotherapeutics. 13(3). 661–675. 5 indexed citations

Iwata, Satoshi, Naohisa Kawamura, Haruo Kuroki, et al.. (2015). Immunogenicity and safety of the 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study. Human Vaccines & Immunotherapeutics. 11(4). 826–837. 5 indexed citations

Dicko, Alassane, Yahia Dicko, Amadou Barry, et al.. (2015). Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study. Human Vaccines & Immunotherapeutics. 11(9). 2207–2214. 3 indexed citations

10.

Lalwani, Sanjay, Sukanta Chatterjee, Jugesh Chhatwal, et al.. (2014). Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Children in India. Clinical and Vaccine Immunology. 21(9). 1292–1300. 7 indexed citations

11.

Odusanya, Olumuyiwa O., Yetunde Kuyinu, Nancy François, et al.. (2013). Safety and immunogenicity of 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Nigerian children. Human Vaccines & Immunotherapeutics. 10(3). 757–766. 7 indexed citations

12.

Prymula, Roman, et al.. (2013). Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol. Vaccine. 31(16). 2080–2088. 37 indexed citations

13.

Dicko, Alassane, Santara Gaoussou, Almahamoudou Mahamar, et al.. (2013). Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children. Human Vaccines & Immunotherapeutics. 9(2). 382–388. 11 indexed citations

14.

François, Nancy, et al.. (2013). Immunogenicity, Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Nigerian Infants: A Randomised Trial. Nigerian Postgraduate Medical Journal. 20(4). 272–272. 2 indexed citations

15.

Lin, Tzou‐Yien, Chun‐Yi Lu, Luan‐Yin Chang, et al.. (2012). Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan. Journal of the Formosan Medical Association. 111(9). 495–503. 11 indexed citations

16.

Bergh, Menno R. van den, Judith Spijkerman, Kristien Swinnen, et al.. (2012). Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial. Clinical Infectious Diseases. 56(3). e30–e39. 112 indexed citations

17.

Dicko, Alassane, Olumuyiwa O. Odusanya, Santara Gaoussou, et al.. (2011). Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial. BMC Public Health. 11(1). 882–882. 20 indexed citations

18.

Omeñaca, Félix, José Merino, Juan Carlos Tejedor Torres, et al.. (2011). Immunization of Preterm Infants With 10-Valent Pneumococcal Conjugate Vaccine. PEDIATRICS. 128(2). e290–e298. 37 indexed citations

19.

Bergh, Menno R. van den, Judith Spijkerman, Nancy François, et al.. (2011). Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands. The Pediatric Infectious Disease Journal. 30(9). e170–e178. 35 indexed citations

20.

Lagos, Rosanna, Alma Muñoz, Myron M. Levine, et al.. (2011). Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children. Human Vaccines. 7(5). 511–522. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact